India's No.1 PU & Degree With Integrated IAS & IPS(UPSC/PSC) Training College.
10Aug 2024
INDIA INTRODUCES BEDAQUILINE, PRETOMANID, AND LINEZOLID(BPAL) REGIMEN FOR DRUG-RESISTANT TUBERCULOSIS
Why in the news? India is set to roll out the BPaL regimen for drug-resistant tuberculosis, reducing treatment time to six months, with training for implementation starting this month. Introduction of BPaL Regimen: India is set to roll out the BPaL regimen, a new treatment for multidrug-resistant (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB) The BPaL …
Read More
